GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,818.00
Bid: 1,812.00
Ask: 1,818.00
Change: -22.00 (-1.20%)
Spread: 6.00 (0.331%)
Open: 1,870.00
High: 1,870.00
Low: 1,814.00
Prev. Close: 1,840.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition of Génétiporc

18 Oct 2013 07:00

RNS Number : 8135Q
Genus PLC
18 October 2013
 



For Immediate Release

18 October 2013

 

 

Genus plc

("Genus")

 

Completion of Acquisition of Génétiporc

 

Genus, a leading global animal genetics company, is pleased to confirm that, further to the announcement on 23 September 2013, it has now completed the acquisition of Génétiporc, the porcine genetics business of Aliments Breton Foods Group, the largest producer and processor of organic and natural pork in North America.  Discussions continue regarding the acquisition by Agroceres PIC, Genus's 49% owned joint venture in Brazil, of Génétiporc's Brazilian joint venture, following the memorandum of understanding agreed in September 2013. 

 

Génétiporc represents an excellent strategic fit with Genus's core activities and has very similar values to Genus's porcine global business unit, PIC. Génétiporc has a strong reputation across the Americas for porcine genetics with a particular emphasis on meat quality, product development, bio-security and health, all of which are also areas of focus for Genus. The acquisition will bring significant opportunities from the combination of the two operations and will further strengthen PIC's market position.

 

 

For further information please contact:

 

Genus plc

Tel: 01256 345970

Karim Bitar, Chief Executive

 

Stephen Wilson, Group Finance Director

 

 

 

 

Buchanan

Tel: 0207 466 5000

Charles Ryland /Sophie McNulty

 

 

This announcement is available on the Genus website www.genusplc.com

 

 

About Genus

Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

 

Genus's worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus' customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.

 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

 

With headquarters in Basingstoke, United Kingdom, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

About Génétiporc

Génétiporc is the porcine breeding business of Aliments Breton Foods Group. It is based in Canada with operations in the US and Mexico and a joint venture in Brazil.

 

Founded in 1984, in response to demand from producers for a swine genetics company that would understand their concerns and would be there to offer solutions, Génétiporc is now one of the leading providers of porcine genetics in North America. It prides itself on its achievements in product development, health and biosecurity and meat quality.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFLAITLDLIV
Date   Source Headline
12th Nov 20078:24 amRNSAdmission to Official List
12th Nov 20078:00 amRNSCancellation - 12/11/2007
7th Nov 20077:57 amRNSPublication of Prospectus
6th Nov 200712:51 pmRNSHolding(s) in Company
6th Nov 20077:00 amRNSDisposal
1st Nov 20075:53 pmRNSDirector/PDMR Shareholding
1st Nov 20077:02 amRNSPlacing
31st Oct 20079:20 amRNSTotal Voting Rights
18th Oct 20072:30 pmRNSDirector/PDMR Shareholding
12th Oct 20077:01 amRNSMove to the Official List
4th Oct 20077:01 amRNSDisposal of SyAqua Mexico
28th Sep 20077:01 amRNSTotal Voting Rights
24th Sep 20072:11 pmRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSPreliminary Results
12th Sep 20072:55 pmRNSStatement re: Foot & Mouth
5th Sep 20075:16 pmRNSBlocklisting Interim Review
17th Aug 20072:55 pmRNSChange of Adviser
10th Aug 20074:28 pmRNSAIM Rule 26
6th Aug 20077:01 amRNSStatement Re: Foot & Mouth
25th Jul 20072:00 pmRNSBlocklisting Interim Review
18th Jul 20077:01 amRNSPre-Close Trading Update
7th Jun 20076:35 pmRNSHolding(s) in Company
7th Jun 20076:33 pmRNSHolding(s) in Company
19th Apr 20075:13 pmRNSDirector/PDMR Shareholding
12th Apr 200710:58 amRNSHolding(s) in Company
29th Mar 20077:00 amRNSHolding(s) in Company
13th Mar 20077:02 amRNSBoard Change
13th Mar 20077:01 amRNSInterim Results
5th Mar 20074:43 pmRNSBlocklisting Interim Review
5th Mar 20077:04 amRNSAdoption of IFRS
2nd Feb 20072:00 pmRNSBlocklisting Interim Review
9th Jan 20077:00 amRNSPre Close Trading Update
15th Dec 20061:19 pmRNSTotal Voting Rights
16th Nov 20063:15 pmRNSResult of AGM
16th Nov 20067:01 amRNSAGM Trading Update
9th Nov 200611:08 amRNSNotification of Interest
11th Oct 20064:05 pmRNSDirector Shareholding
11th Oct 20067:00 amRNSDisposal
20th Sep 20067:02 amRNSPreliminary Results
6th Sep 20067:00 amRNSBlocklisting Interim Review
17th Aug 20063:49 pmRNSNotice of Results
16th Aug 20061:15 pmRNSHolding(s) in Company
21st Jul 20062:07 pmRNSAdditional Listing
23rd Jun 20062:26 pmRNSDirectors' Share Awards
14th Jun 20069:02 amRNSDisposal
7th Jun 20067:01 amRNSInterim Results
15th May 20061:40 pmRNSNotice of Results
5th Apr 20067:00 amRNSPre-Close Trading Update
7th Mar 200612:17 pmRNSDirector/PDMR Shareholding
28th Feb 20064:06 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.